Plasminogen deficiency

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 12, 2007, Pages 2315-2322

  Schuster, Volker ^a   Hugle B ^a   Tefs, K ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Conjunctivitis; Dysplasminogenemia; Hypoplasminogenemia; Ligneous; Plg gene mutations; Thrombosis

Indexed keywords

CHYMOTRYPSIN A; CORTICOSTEROID; FRESH FROZEN PLASMA; HEPARIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PLASMIN; PLASMINOGEN; PLASMINOGEN[LYSINE]; PREDNISOLONE; SEX HORMONE; STANOZOLOL; TRANEXAMIC ACID;

ASCITES; BLOOD DISEASE; CLEARANCE; CLINICAL RESEARCH; CONJUNCTIVITIS; CONTINUOUS INFUSION; DRUG MEGADOSE; GENETIC POLYMORPHISM; GINGIVITIS; HORMONAL THERAPY; HUMAN; HYDROCEPHALUS; KNOCKOUT MOUSE; MENORRHAGIA; MUCOSAL DISEASE; NONHUMAN; PERIODONTAL DISEASE; PLASMINOGEN DEFICIENCY; PRIORITY JOURNAL; REVIEW; SUBSTITUTION THERAPY; VEIN THROMBOSIS; WOUND HEALING IMPAIRMENT;

AMINO ACID SEQUENCE; ANIMALS; BLOOD COAGULATION DISORDERS; CONJUNCTIVITIS; DISEASE MODELS, ANIMAL; FIBRINOLYSIS; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MUTATION; PHENOTYPE; PLASMIN; PLASMINOGEN; PROTEIN CONFORMATION; RISK ASSESSMENT; RISK FACTORS; VENOUS THROMBOSIS;

EID: 36348973495     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02776.x     Document Type: Review

References (84)

1. Castellino FJ, Ploplis VA. Structure and function of the plasminogen/ plasmin system. Thromb Haemost 2005; 93: 647-54.
2. Bugge TH, Flick MJ, Danton MJ, Daugherty CC, Romer J, Dano K, Carmeliet P, Collen D, Degen JL. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. Proc Natl Acad Sci USA 1996; 93: 5899-904.
3. Collen D, Lijnen HR. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood 1991; 78: 3114-24.
4. Petersen TE, Martzen MR, Ichinose A, Davie EW. Characterization of the gene for human plasminogen, a key proenzyme in the fibrinolytic system. J Biol Chem 1990; 265: 6104-11.
5. Hasegawa D, Tyler B, Edson JR. Thrombotic disease in three families with inherited plasminogen deficiency. Blood 1982; 60: 213a.
6. Dolan G, Greaves M, Cooper P, Preston FE. Thrombovascular disease and familial plasminogen deficiency: A report of three kindreds. Br J Haematol 1988; 70: 417-21.
7. Leebeek FW, Knot EA, Ten Cate JW, Traas DW. Severe thrombotic tendency associated with a type I plasminogen deficiency. Am J Hematol 1989; 30: 32-5.
8. Lottenberg R, Dolly FR, Kitchens CS. Recurring thromboembolic disease and pulmonary hypertension associated with severe hypoplasminogenemia. Am J Hematol 1985; 19: 181-93.
9. Sartori MT, Patrassi GM, Theodoridis P, Perin A, Pietrogrande F, Girolami A. Heterozygous type I plasminogen deficiency is associated with an increased risk for thrombosis: A statistical analysis in 20 kindreds. Blood Coagul Fibrinolysis 1994; 5: 889-93.
10. Demarmels Biasiutti F, Sulzer I, Stucki B, Wuillemin WA, Furlan M, Lammle B. Is plasminogen deficiency a thrombotic risk factor? A study on 23 thrombophilic patients and their family members Thromb Haemost 1998; 80: 167-70.
11. Shigekiyo T, Uno Y, Tomonari A, Satoh K, Hondo H, Ueda S, Saito S. Type I congenital plasminogen deficiency is not a risk factor for thrombosis. Thromb Haemost 1992; 67: 189-92.
12. Tait RC, Walker ID, Conkie JA, Islam SI, McCall F. Isolated familial plasminogen deficiency may not be a risk factor for thrombosis. Thromb Haemost 1996; 76: 1004-8.
13. Biasiutti FD, Stucki B, Solenthaler M, Tobler A, Furlan M, Lammle B. Venous thrombosis after caesarean section in a young woman with homozygous APC resistance and type I protein S deficiency. Eur J Haematol 1997; 58: 127-9.
14. Brandt JT. Plasminogen and tissue-type plasminogen activator deficiency as risk factors for thromboembolic disease. Arch Pathol Lab Med 2002; 126: 1376-81.
15. Schott D, Dempfle CE, Beck P, Liermann A, Mohr-Pennert A, Goldner M, Mehlem P, Azuma H, Schuster V, Mingers AM, Schwarz HP, Kramer MD. Therapy with a purified plasminogen concentrate in an infant with ligneous conjunctivitis and homozygous plasminogen deficiency. N Engl J Med 1998; 339: 1679-86.
16. Schuster V, Mingers AM, Seidenspinner S, Nüssgens Z, Pukrop T, Kreth W. Homozygous mutations in the plasminogen gene of two unrelated girls with ligneous conjunctivitis. Blood 1997; 90: 958-66.
17. Schuster V, Seidenspinner S, Zeitler P, Escher C, Pleyer U, Bernauer W, Stiehm ER, Isenberg S, Seregard S, Olsson T, Mingers AM, Schambeck C, Kreth HW. Compound-heterozygous mutations in the plasminogen gene predispose to the development of ligneous conjunctivitis. Blood 1999; 93: 3457-66.
18. Schuster V, Zeitler P, Seregard S, Ozcelik U, Anadol D, Luchtman-Jones L, Meire F, Mingers AM, Schambeck C, Kreth HW. Homozygous and compound-heterozygous type I plasminogen deficiency is a common cause of ligneous conjunctivitis. Thromb Haemost 2001; 85: 1004-10.
19. Tefs K, Gueorguieva M, Klammt J, Allen CM, Aktas D, Anlar FY, Aydogdu SD, Brown D, Ciftci E, Contarini P, Dempfle CE, Dostalek M, Eisert S, Gokbuget A, Gunhan O, Hidayat AA, Hugle B, Isikoglu M, Irkec M, Joss SK, et al. Molecular and clinical spectrum of type I plasminogen deficiency: a series of 50 patients. Blood 2006; 108: 3021-6.
20. Drew AF, Kaufman AH, Kombrinck KW, Danton MJ, Daugherty CC, Degen JL, Bugge TH. Ligneous conjunctivitis in plasminogen-deficient mice. Blood 1998; 91: 1616-24.
21. Bugge TH, Flick MJ, Daugherty CC, Degen JL. Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev 1995; 9: 794-807.
22. Bugge TH, Kombrinck KW, Flick MJ, Daugherty CC, Danton MJ, Degen JL. Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell 1996; 87: 709-19.
23. Ploplis VA, Carmeliet P, Vazirzadeh S, Van Vlaenderen I, Moons L, Plow EF, Collen D. Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. Circulation 1995; 92: 2585-93.
24. Dykes D, Polesky H. Incindence of the PLG *Q0 allele in human populations. In: Mayr W, ed. Advanced in Forensic Haemogenetics. Berlin: Springer, 1988: 261-4.
25. Weidinger S, Patutschnick W, Schwarzfischer F. Further evidence of a silent plasminogen (PLG) allele in two paternity cases. Z Rechtsmed 1988; 101: 99-104.
26. Okamoto A, Sakata T, Mannami T, Baba S, Katayama Y, Matsuo H, Yasaka M, Minematsu K, Tomoike H, Miyata T. Population-based distribution of plasminogen activity and estimated prevalence and relevance to thrombotic diseases of plasminogen deficiency in the Japanese: The Suita Study. J Thromb Haemost 2003; 1: 2397-403.
27. Tefs K, Tait CR, Walker ID, Pietzsch N, Ziegler M, Schuster V. A K19E missense mutation in the plasminogen gene is a common cause of familial hypoplasminogenaemia. Blood Coagul Fibrinolysis 2003; 14: 411-6.
28. Azuma H, Uno Y, Shigekiyo T, Saito S. Congenital plasminogen deficiency caused by a Ser572 to Pro mutation. Blood 1993; 82: 475-80.
29. Schuster V, Seregard S. Ligneous conjunctivitis. Surv Ophthalmol 2003; 48: 369-88.
30. Mingers AM, Heimburger N, Zeitler P, Kreth HW, Schuster V. Homozygous type I plasminogen deficiency. Semin Thromb Hemost 1997; 23: 259-69.
31. Pantanowitz L, Bauer K, Tefs K, Schuster V, Balogh K, Pilch BZ, Adcock D, Cirovic C, Kocher O. Ligneous (pseudomembranous) inflammation involving the female genital tract associated with type-1 plasminogen deficiency. Int J Gynecol Pathol 2004; 23: 292-5.
32. Diamond JP, Chandna A, Williams C, Easty DL, Scully C, Eveson J, Richards A. Tranexamic acid-associated ligneous conjunctivitis with gingival and peritoneal lesions. Br J Ophthalmol 1991; 75: 753-4.
33. Heidemann DG, Williams GA, Hartzer M, Ohanian A, Citron ME. Treatment of ligneous conjunctivitis with topical plasmin and topical plasminogen. Cornea 2003; 22: 760-2.
34. Watts P, Suresh P, Mezer E, Ells A, Albisetti M, Bajzar L, Marzinotto V, Andrew M, Massicotle P, Rootman D. Effective treatment of ligneous conjunctivitis with topical plasminogen. Am J Ophthalmol 2002; 133: 451-5.
35. Tabbara KF. Prevention of ligneous conjunctivitis by topical and subconjunctival fresh frozen plasma. Am J Ophthalmol 2004; 138: 299-300.
36. De Cock R, Ficker LA, Dart JG, Garner A, Wright P. Topical heparin in the treatment of ligneous conjunctivitis. Ophthalmology 1995; 102: 1654-9.
37. Acs N, Vajo Z, Miklos Z, Siklosi G, Paulin F, Felicetta JV, Szekacs B. The effects of postmenopausal hormone replacement therapy on hemostatic variables: A meta-analysis of 46 studies. Gynecol Endocrinol 2002; 16: 335-46.
38. Mannucci PM, Kluft C, Traas DW, Seveso P, D'Angelo A. Congenital plasminogen deficiency associated with venous thromboembolism: therapeutic trial with stanozolol. Br J Haematol 1986; 63: 753-9.
39. Saidi P, Lega BZ, Kim HC, Raska K Jr. Effect of danazol on clotting factor levels, bleeding incidence, factor infusion requirements, and immune parameters in hemophilia. Blood 1986; 68: 673-9.
40. Sartori TM, Saggiorato G, Pellati D, Casonato A, Spiezia L, Pontara E, Gavasso S, Girolami A. Contraceptive pills induce an improvement in congenital hypoplasminogenemia in two unrelated patients with ligneous conjuncitivits. Thromb Haemost 2003; 90: 86-91.
41. Shigekiyo T, Tomonari A, Uno Y, Kishi Y. Danazol therapy in hypoplasminogenemia. Thromb Haemost 1992; 68: 233-4.
42. Silva GB, Bariani C, Mendonca EF, Batista AC. Clinical manifestations due to severe plasminogen deficiency: A case report. J Dent Child (Chic) 2006; 73: 179-82.
43. Bulens F, Merchiers P, Ibanez-Tallon I, De Vriese A, Nelles L, Claessens F, Belayew A, Collen D. Identification of a multihormone responsive enhancer far upstream from the human tissue-type plasminogen activator gene. J Biol Chem 1997; 272: 663-71.
44. Kraft J, Lieb W, Zeitler P, Schuster V. Ligneous conjunctivitis in a girl with severe type I plasminogen deficiency. Graefes Arch Clin Exp Ophthalmol 2000; 238: 797-800.
45. Eriksson PO, Li J, Ny T, Hellstrom S. Spontaneous development of otitis media in plasminogen-deficient mice. Int J Med Microbiol 2006; 296: 501-9.
46. Lijnen HR, Carmeliet P, Bouche A, Moons L, Ploplis VA, Plow EF, Collen D. Restoration of thrombolytic potential in plasminogen-deficient mice by bolus administration of plasminogen. Blood 1996; 88: 870-6.
47. Romer J, Bugge TH, Pyke C, Lund LR, Flick MJ, Degen JL, Dano K. Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med 1996; 2: 287-92.
48. Hoover-Plow J, Wang N, Ploplis V. Growth and behavioral development in plasminogen gene-targeted mice. Growth Dev Aging 1999; 63: 13-32.
49. Hoover-Plow J, Ellis J, Yuen L. In vivo plasminogen deficiency reduces fat accumulation. Thromb Haemost 2002; 87: 1011-9.
50. Ny A, Leonardsson G, Hagglund AC, Hagglof P, Ploplis VA, Carmeliet P, Ny T. Ovulation in plasminogen-deficient mice. Endocrinology 1999; 140: 5030-5.
51. Lund LR, Bjorn SF, Sternlicht MD, Nielsen BS, Solberg H, Usher PA, Osterby R, Christensen IJ, Stephens RW, Bugge TH, Dano K, Werb Z. Lactational competence and involution of the mouse mammary gland require plasminogen. Development 2000; 127: 4481-92.
52. Hoover-Plow J, Skomorovska-Prokvolit O, Welsh S. Selective behaviors altered in plasminogen-deficient mice are reconstituted with intracerebroventricular injection of plasminogen. Brain Res 2001; 898: 256-64.
53. Wang N, Zhang L, Miles L, Hoover-Plow J. Plasminogen regulates pro-opiomelanocortin processing. J Thromb Haemost 2004; 2: 785-96.
54. Coleman JL, Gebbia JA, Piesman J, Degen JL, Bugge TH, Benach JL. Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice. Cell 1997; 89: 1111-9.
55. Gebbia JA, Monco JC, Degen JL, Bugge TH, Benach JL. The plasminogen activation system enhances brain and heart invasion in murine relapsing fever borreliosis. J Clin Invest 1999; 103: 81-7.
56. Nordstrand A, Shamaei-Tousi A, Ny A, Bergstrom S. Delayed invasion of the kidney and brain by Borrelia crocidurae in plasminogen-deficient mice. Infect Immun 2001; 69: 5832-9.
57. Li Z, Ploplis VA, French EL, Boyle MD. Interaction between group A streptococci and the plasmin(ogen) system promotes virulence in a mouse skin infection model. J Infect Dis 1999; 179: 907-14.
58. Ringdahl U, Svensson M, Wistedt AC, Renne T, Kellner R, Muller-Esterl W, Sjobring U. Molecular co-operation between protein PAM and streptokinase for plasmin acquisition by Streptococcus pyogenes. J Biol Chem 1998; 273: 6424-30.
59. Goguen JD, Bugge T, Degen JL. Role of the pleiotropic effects of plasminogen deficiency in infection experiments with plasminogen-deficient mice. Methods 2000; 21: 179-83.
60. Carmeliet P, Moons L, Ploplis V, Plow E, Collen D. Impaired arterial neointima formation in mice with disruption of the plasminogen gene. J Clin Invest 1997; 99: 200-8.
61. Bezerra JA, Bugge TH, Melin-Aldana H, Sabla G, Kombrinck KW, Witte DP, Degen JL. Plasminogen deficiency leads to impaired remodeling after a toxic injury to the liver. Proc Natl Acad Sci USA 1999; 96: 15143-8.
62. Creemers E, Cleutjens J, Smits J, Heymans S, Moons L, Collen D, Daemen M, Carmeliet P. Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction. Am J Pathol 2000; 156: 1865-73.
63. Lugea A, Nan L, French SW, Bezerra JA, Gukovskaya AS, Pandol SJ. Pancreas recovery following cerulein-induced pancreatitis is impaired in plasminogen-deficient mice. Gastroenterology 2006; 131: 885-99.
64. Kitching AR, Holdsworth SR, Ploplis VA, Plow EF, Collen D, Carmeliet P, Tipping PG. Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J Exp Med 1997; 185: 963-8.
65. Busso N, Peclat V, Van Ness K, Kolodziesczyk E, Degen J, Bugge T, So A. Exacerbation of antigen-induced arthritis in urokinase-deficient mice. J Clin Invest 1998; 102: 41-50.
66. Bugge TH, Kombrinck KW, Xiao Q, Holmback K, Daugherty CC, Witte DP, Degen JL. Growth and dissemination of Lewis lung carcinoma in plasminogen-deficient mice. Blood 1997; 90: 4522-31.
67. Bugge TH, Lund LR, Kombrinck KK, Nielsen BS, Holmback K, Drew AF, Flick MJ, Witte DP, Dano K, Degen JL. Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice. Oncogene 1998; 16: 3097-104.
68. Moons L, Shi C, Ploplis V, Plow E, Haber E, Collen D, Carmeliet P. Reduced transplant arteriosclerosis in plasminogen-deficient mice. J Clin Invest 1998; 102: 1788-97.
69. Xiao Q, Danton MJ, Witte DP, Kowala MC, Valentine MT, Bugge TH, Degen JL. Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis. Proc Natl Acad Sci USA 1997; 94: 10335-40.
70. Swaisgood CM, Aronica MA, Swaidani S, Plow EF. Plasminogen is an Important Regulator in the Pathogenesis of a Murine Model of Asthma. Am J Respir Crit Care Med 2007; 176: 333-42.
71. Tsirka SE, Rogove AD, Bugge TH, Degen JL, Strickland S. An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neurosci 1997; 17: 543-52.
72. Chen ZL, Strickland S. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 1997; 91: 917-25.
73. Robbins KC. Classification of abnormal plasminogens: dysplasminogenemias. Semin Thromb Hemost 1990; 16: 217-20.
74. Aoki N, Moroi M, Sakata Y, Yoshida N, Matsuda M. Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis. J Clin Invest 1978; 61: 1186-95.
75. Ooe A, Kida M, Yamazaki T, Park SC, Hamaguchi H, Girolami A, Ichinose A. Common mutation of plasminogen detected in three Asian populations by an amplification refractory mutation system and rapid automated capillary electrophoresis. Thromb Haemost 1999; 82: 1342-6.
76. Tsutsumi S, Saito T, Sakata T, Mlyata T, Ichinose A. Genetic diagnosis of dysplasminogenemia: Detection of an Ala601-Thr mutation in 118 out of 125 families and identification of a new Asp676-Asn mutation.Thromb. Haemost 1996; 76: 135-8.
77. Baumann-Baretti B, Vetter V, Kiesewetter H, Ziemer S, Kulozik A. Unusually severe thrombophilia in dysplasminogenemia: Profound disruption of plasmin generation caused by a novel L696P amino acid substitution in the enzymatically active Alpha-Helix. Blood 2000; 96: 52a.
78. Kikuchi S, Yamanouchi Y, Li L, Kobayashi K, Ijima H, Miyazaki R, Tsuchiya S, Hamaguchi H. Plasminogen with type-I mutation is polymorphic in the Japanese population. Hum Genet 1992; 90: 7-11.
79. Li L, Kikuchi S, Arinami T, Kobayashi K, Tsuchiya S, Hamaguchi H. Plasminogen with type-I mutation in the Chinese Han population. Clin Genet 1994; 45: 285-7.
80. Ichinose A, Espling ES, Takamatsu J, Saito H, Shinmyozu K, Maruyama I, Petersen TE, Davie EW. Two types of abnormal genes for plasminogen in families with a predisposition for thrombosis. Proc Natl Acad Sci USA 1991; 88: 115-9.
81. Scharrer I, Hach-Wunderle V, Wohl RC, Sinio L, Boreisha I, Robbins KC. Congenital abnormal plasminogen, Frankfurt I, a cause for recurrent venous thrombosis. Haemostasis 1988; 18(Suppl. 1): 77-86.
82. Shigekiyo T, Kanazuka M, Aihara K, Azuma H, Ohshima Y, Horie H, Nakahira H, Takeichi T, Matsumoto T. No increased risk of thrombosis in heterozygous congenital dysplasminogenemia. Int J Hematol 2000; 72: 247-52.
83. Yamaguchi M, Sugiyama S, Noda H, Tatsumi S, Yoshimura M. A novel missense mutation D676N in the plasminogen gene causes loss of functional activity. Hum Hered 1997; 47: 234-6.
84. Higuchi Y, Furihata K, Ueno I, Ishikawa S, Okumura N, Tozuka M, Sakurai N. Plasminogen Kanagawa-I, a novel missense mutation, is caused by the amino acid substitution G732R. Br J Haematol 1998; 103: 867-70.